Hippurate-131I for injection

Radionuclidic purity: 

≥ 99.9%

Radiochemical purity: 

≥ 96%


7 days


Hippurate-131I for injection expires 21 days from manufacturing date.


Store in refrigerator (2OC - 8OC).
During transportation (not longer than 7 days after production date) up to 25OC.

Pharmaceutical form: 

Solution for injection.

Active substance: 

Sodium 2-[131I]iodohippurate 3.7 - 74 MBq/ml


benzyl alcohol
sodium chloride
water for injection


10 ml glass vial sealed with a rubber stopper and an aluminum crimp cap, placed in a lead shielding container. The vial contains a volume of the solution corresponding to the activity determined  on the calibration day.


Hippurate-131I is a radiopharmaceutical used in diagnostics of kidneys dysfunction and urinary tract obstructions (dynamic renal scintigraphy, renoscintigraphy).
Renal scintigraphy utilizing this radiopharmaceutical allows the evaluation of:
• kidney blood flow resolution (effective renal plasma flow – ERPF),
• renal tubular  function,
• urine outflow from the pyelocalyceal system,
• vesico-ureteral reflux (examination during miction),
• renal function impairment in transplanted kidney
and can be used in the diagnostics of renovascular hypertension (particularly in the captopril enhanced renal scintigraphy).
The preparation accumulates in the kidneys where it concentrates and is later excreted.




Our product range includes radiopharmaceuticals, radiochemicals, radioactivity standards and sealed radiation sources. We offer a broad selection of services and workshops, and training.

About Us

National Centre for Nuclear Research, Radioisotope Centre POLATOM is manufacturer and distributor of the isotopic goods applied in medicine, research and development, industry and environment protection.


The high professionalism of our company has been confirmed by a number of certificates including GMP for radiopharmaceutical production.